In Focus: Clinical Trials

| 01 June 2009

The demand to develop drugs, devices and treatment regimens faster and at lower cost has exerted enormous pressure on drug development, particularly over the past 10 years. Financial costs have driven this business in extraordinary and sometimes unforeseen ways. Global outsourcing is one area that has received significant attention. This issue examines globalization as it relates to cost containment of clinical trials. We also look at other cost themes: opportunity, patient (safety), regulatory and reimbursement.


© 2023 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy